Bpr Medical, Ltd.

Bpr Medical, Ltd. specializes in medical gas-related devices, including dial-type medical gas flowmeters, demand valves, and fixed regulators for medical gas cylinders. Their portfolio also includes the BABYCARE NEO₂ Oxygen Concentration Controller, which is specifically designed for controlled oxygen delivery in neonatal care settings. These devices are engineered to ensure precise and safe administration of medical gases in clinical environments.

Bpr Medical, Ltd. is based in the United States. Since the company operates within the U.S., its devices fall under the jurisdiction of the FDA (Food and Drug Administration). This means their products are regulated through pathways like the 510(k) clearance process and must comply with UDI (Unique Device Identification) requirements, ensuring traceability and transparency in the medical device supply chain.

Bpr Medical, Ltd.’s devices are listed in the FDA’s 510(k) and UDI registries. These registries are critical because they provide official documentation of device clearance and compliance with U.S. regulations. The 510(k) process demonstrates that a device is substantially equivalent to a legally marketed predicate device, while UDI ensures each device can be uniquely identified throughout its lifecycle, improving patient safety and regulatory tracking.

Bpr Medical, Ltd.’s devices are classified as either Class I or Class II under FDA regulations. Class I devices generally pose the lowest risk and are subject to general controls, such as proper labeling and manufacturing practices. Class II devices involve a higher level of risk and require special controls in addition to general controls, such as performance standards or post-market surveillance. The classification determines the regulatory scrutiny and compliance requirements each device must meet to ensure safety and effectiveness.